Conference
179P Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) monotherapy in US clinical practice
Authors
Frueh M; Rahma OE; Pachynski RK; Mazieres J; Goldschmidt J; Ton TGN; Mhatre SK; Chuo C-Y; Martinalbo J; Davies J
Volume
30
Publisher
Elsevier
Publication Date
April 1, 2019
DOI
10.1093/annonc/mdz063.077
Conference proceedings
Annals of Oncology
ISSN
0923-7534